News
Meet us at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
GenoScreen will be present at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) on April 13 in Amsterdam.
Next trainings
Sign up for our command line trainings at NGS data analysis from March 19th to 26rd, 2019.
Meet us at the POLEPHARMA Microbiomics Days
GenoScreen will participate in the 1st edition of the POLEPHARMA Microbiomics Days which will be organized on April 9 & 10 at the HEALTH UFR of the University of Rouen.
Meet us at BioFIT 2018!
On the 4th and 5th of December 2018, GenoScreen will participate at the 7th edition of the BioFIT business convention which will take place this year in Lille Grand Palais.
World TB Day: GenoScreen participates to the International Tuberculosis Conference in Brussels!
On March 21st, GenoScreen will participate in the "International Conference on Tuberculosis" in Brussels.
Metabiote® protocol is now GCLP compliant
Metabiote®, the reference protocol in targeted metagenomics developed by GenoScreen, is now GCLP compliant.
GenoScreen finalizes a €1 million fundraising campaign to continue its international expansion
GenoScreen announced today that it has completed a €1 million fundraising campaign with private investors.
Pioneer company since 2001 in sequencing, genotyping and bioinformatics, GenoScreen provides innovative services and solutions in genomics to address the needs of academic and industrial research teams. At the forefront of genomics in France, GenoScreen develops innovation programs that fuel its technological lead and generate high-performance analytical, products and control services.
A major advance in the fight against multidrug-resistant tuberculosis
Deeplex®-MycTB, was used in a study published in The Lancet Infectious Diseases highlighting the spread of tuberculosis strains resistant to first-line antibiotics, not detected by current diagnostic tests.
Page 1 of 2